32
Views
14
CrossRef citations to date
0
Altmetric
Correspondence

Topical application of imiquimod for the treatment of high‐risk facial basal cell carcinoma in Gorlin syndrome

, , &
Pages 120-121 | Published online: 12 Jul 2009

References

  • Gorlin RJ, Nevoid basal cell carcinoma syndrome. Dermatol Clin (1995) 13: 113–25.
  • Dahl MV, Imiquimod: a cytokine inducer. J Am Acad Dermatol (2002) 47(4): S205–208.
  • Micali G, De Pasquale R, Caltabiano R et al, Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. J Dermatol Treat (2002) 13: 123–7.
  • Kagy MK, Amonette R, The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg (2000) 26(6): 577–9.
  • Sockfleth E, Ulrich C, Hauschild A et al, Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol (2002) 12: 569–72.
  • Cowen E, Mercurio MG, Gaspari AA, An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream. J Am Acad Dermatol (2002) 47: S240–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.